| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Radiation Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114
Active and passive immune resistance to implanted syngeneic sarcoma cells was expressed more effectively in visceral organs reached by intravascular implantation than in i.m. and s.c. implantation sites. Passive transfer of serum from tumor-cured as well as tumor-bearing donors gave resistance to unsensitized sublethally radiated recipients partially restored with transferred normal lymph node cells.
1 This work was supported in part by USPHS Grants CA05047, CA11138, and CA13018 and by a Cancer Research Scholar Award from the American Cancer Society, Massachusetts Division. This work was begun at the University of Texas, M. D. Anderson Hospital and Tumor Institute, and completed at the Massachusetts General Hospital.
Received 12/ 4/72. Accepted 4/27/73.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |